Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRUKER CORPBRKR · Entity 3609 | Director | February 15, 2026 | February 18, 2026 |
| INVIVO THERAPEUTICS HOLDINGS CORP.NVIV · Entity 94539 | Director | November 17, 2022 | November 21, 2022 |
| SAFEGUARD SCIENTIFICS INCSFE · Entity 9612 | Director | April 15, 2022 | April 18, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRUKER CORP
Report date February 15, 2026 · Filed February 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,781 |
Reported balance
After 2026-02-15 transaction · row 1
1 source rowRow 1 · 2026-02-15 · Grant · Acquired 4,520 · Balance 38,781 F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.
INVIVO THERAPEUTICS HOLDINGS CORP.
Report date November 17, 2022 · Filed November 21, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.50 · Expires 2032-11-16 | Direct | 4,200 |
Reported balance
After 2022-11-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-11-17 · Grant · Acquired 4,200 · Balance 4,200 F1: The option was granted on November 17, 2022. 100% of the shares shall vest on November 17, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The option was granted on November 17, 2022. 100% of the shares shall vest on November 17, 2023.
SAFEGUARD SCIENTIFICS INC
Report date April 15, 2022 · Filed April 18, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 81,855 |
Reported balance
After 2022-04-15 transaction · row 1
1 source rowRow 1 · 2022-04-15 · Grant · Acquired 5,400 · Balance 81,855 F1: The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2026 Filed Feb 18, 2026 21:15 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 4,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001203911-26-000002 · form4-02182026_040214.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,781 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:38 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 3,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-004654 · form4-02192025_090249.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,261 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2026. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:39 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 10,000 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0001415889-24-021463 · form4-08162024_080826.xml · derivative · entry 5 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2026-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Stock Option granted to the Reporting Person on January 5, 2016 (the "Original Grant Date") vests in equal installments on the first, second and third anniversaries of the Original Grant Date. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:39 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 2,500 | $0.00 Strike: $20.83 | $0.00 |
DisclosureSEC source: 0001415889-24-021463 · form4-08162024_080826.xml · derivative · entry 4 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2025-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Stock Option granted to the Reporting Person on November 12, 2015 (the "Original Grant Date") vests in equal installments on the first, second and third anniversaries of the Original Grant Date. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:39 UTC | BRUKER CORP BRKR · Entity 3609 | SaleCommon Stock | 4,684 | $63.14 | $295,747.76 |
DisclosureSEC source: 0001415889-24-021463 · form4-08162024_080826.xml · nonDerivative · entry 3 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,963 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.81 to $63.28, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:39 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionCommon Stock | 10,000 | $24.00 | $240,000.00 |
DisclosureSEC source: 0001415889-24-021463 · form4-08162024_080826.xml · nonDerivative · entry 2 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:39 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionCommon Stock | 2,500 | $20.83 | $52,075.00 |
DisclosureSEC source: 0001415889-24-021463 · form4-08162024_080826.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:05 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000851 · form4-01092024_090116.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,147 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2025. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 21:24 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 1,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-000680 · form4-01092023_090105.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,770 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2024. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 17:04 UTC | INVIVO THERAPEUTICS HOLDINGS CORP. NVIV · Entity 94539 | GrantStock Option (right to buy) · Derivative | 4,200 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001104659-22-120829 · tm2231056-6_4seq1.xml · derivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,200 Underlying: Common Stock · 4,200 shares Expires 2032-11-16 F1 · derivative.exercise_date: The option was granted on November 17, 2022. 100% of the shares shall vest on November 17, 2023. Read SEC document |
| April 15, 2022 Filed Apr 18, 2022 11:29 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 5,400 | $4.94 | $26,649.00 |
DisclosureSEC source: 0001437749-22-009063 · rdgdoc.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,855 F1 · price: The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter. Read SEC document |
| January 17, 2022 Filed Jan 18, 2022 13:54 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 3,913 | $7.10 | $27,782.30 |
DisclosureSEC source: 0001437749-22-001011 · rdgdoc.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,455 F1 · price: The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 21:10 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 1,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000304 · edgar.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,800 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2023. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 13:28 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 3,236 | $8.30 | $26,858.80 |
DisclosureSEC source: 0001437749-21-023792 · rdgdoc.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,542 F1 · price: The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 13:33 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 3,803 | $7.95 | $30,243.36 |
DisclosureSEC source: 0001437749-21-017044 · rdgdoc.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,306 F1 · price: The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter. Read SEC document |
| June 30, 2021 Filed Jun 30, 2021 16:29 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 10,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-016018 · rdgdoc.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,503 Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 15:25 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 3,995 | $6.58 | $26,297.09 |
DisclosureSEC source: 0001437749-21-009089 · rdgdoc.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,080 F1 · price: The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 21:31 UTC | INVIVO THERAPEUTICS HOLDINGS CORP. NVIV · Entity 94539 | GrantStock option (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001179110-21-003699 · edgar.xml · derivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common stock · 15,000 shares Expires 2031-03-17 F1 · derivative.exercise_date: This option was granted on March 18, 2021. The shares underlying the option will vest in their entirety on March 18, 2022. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 13:17 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 4,281 | $6.63 | $28,378.32 |
DisclosureSEC source: 0001437749-21-000810 · rdgdoc.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,085 F1 · price: The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:15 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 2,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000401 · edgar.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,959 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2022. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 15:10 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 4,918 | $6.00 | $29,508.00 |
DisclosureSEC source: 0001437749-20-021209 · rdgdoc.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,804 F1 · price: The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter. Read SEC document |
| July 15, 2020 Filed Jul 16, 2020 16:13 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 4,176 | $6.29 | $26,246.16 |
DisclosureSEC source: 0001437749-20-015242 · rdgdoc.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,886 F1 · price: The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter. Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 15:21 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 10,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-014316 · rdgdoc.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,710 Read SEC document |
| May 11, 2020 Filed May 12, 2020 14:42 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | PurchaseCommon Stock | 2,343 | $6.40 | $14,995.20 |
DisclosureSEC source: 0001437749-20-010358 · rdgdoc.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,818 Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 18:26 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 5,212 | $5.44 | $28,366.31 |
DisclosureSEC source: 0001437749-20-007867 · rdgdoc.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,475 F1 · price: The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter. Read SEC document |
| January 22, 2020 Filed Jan 23, 2020 19:33 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 2,525 | $10.91 | $27,547.75 |
DisclosureSEC source: 0000086115-20-000010 · wf-form4_157980801318345.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,263 F1 · price: The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter. Read SEC document |
| January 13, 2020 Filed Jan 13, 2020 16:54 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $14.10 | $0.00 |
DisclosureSEC source: 0000086115-20-000002 · wf-form4_157893442383907.xml · derivative · entry 2 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2020-05-24 F1 · derivative.exercise_price: The exercise price was reduced by $0.96 to reflect the impact of a dividend paid to the Issuer's shareholders in December 2019. Read SEC document |
| January 13, 2020 Filed Jan 13, 2020 16:54 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $15.06 | $0.00 |
DisclosureSEC source: 0000086115-20-000002 · wf-form4_157893442383907.xml · derivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2020-05-24 Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 16:50 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 2,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-000356 · edgar.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,657 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 6, 2021. Read SEC document |
| June 30, 2019 Filed Jul 1, 2019 16:12 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 6,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-008471 · wf-form4_156199755724233.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,738 Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 17:01 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 4,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000642 · edgar.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,185 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 7, 2020. Read SEC document |
| July 31, 2018 Filed Aug 1, 2018 15:02 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantCommon Stock | 6,066 | $0.00 | $0.00 |
DisclosureSEC source: 0000086115-18-000072 · wf-form4_153313574400647.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,643 Read SEC document |
| May 09, 2018 Filed May 10, 2018 13:46 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $12.29 Strike: $12.29 | $61,469.00 |
DisclosureSEC source: 0000086115-18-000054 · wf-form4_152595995657235.xml · derivative · entry 3 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2018-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2018 Filed May 10, 2018 13:46 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 4,579 | $13.43 | $61,473.08 |
DisclosureSEC source: 0000086115-18-000054 · wf-form4_152595995657235.xml · nonDerivative · entry 2 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,577 Read SEC document |
| May 09, 2018 Filed May 10, 2018 13:46 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Exercise / conversionCommon Stock | 5,000 | $12.29 | $61,469.00 |
DisclosureSEC source: 0000086115-18-000054 · wf-form4_152595995657235.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 20:59 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 3,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-000732 · edgar.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,051 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on January 5, 2019. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 18:35 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Exercise / conversionStock Option (right to buy) · Derivative | 4,166 | $0.00 Strike: $10.94 | $0.00 |
DisclosureSEC source: 0000086115-17-000095 · wf-form4_150230368643722.xml · derivative · entry 3 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,166 shares Expires 2017-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 18:35 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Tax withholdingCommon Stock | 3,807 | $11.98 | $45,588.83 |
DisclosureSEC source: 0000086115-17-000095 · wf-form4_150230368643722.xml · nonDerivative · entry 2 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,156 Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 18:35 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | Exercise / conversionCommon Stock | 4,166 | $10.94 | $45,577.29 |
DisclosureSEC source: 0000086115-17-000095 · wf-form4_150230368643722.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2017 Filed May 31, 2017 17:27 UTC | SAFEGUARD SCIENTIFICS INC SFE · Entity 9612 | GrantDeferred Stock Unit Award 2017 · Derivative | 7,406 | $0.00 | $0.00 |
DisclosureSEC source: 0000086115-17-000072 · wf-form4_149625165562438.xml · derivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,406 Underlying: Common Stock · 7,406 shares Expires not disclosed F1 · derivative.exercise_price: The deferred stock units are payable in stock, on a one-for-one basis. The deferred stock units vest on the first anniversary of the grant date or once a director reaches age 65. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer F1 · derivative.exercise_date: The deferred stock units are payable in stock, on a one-for-one basis. The deferred stock units vest on the first anniversary of the grant date or once a director reaches age 65. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer F1 · derivative.expiration_date: The deferred stock units are payable in stock, on a one-for-one basis. The deferred stock units vest on the first anniversary of the grant date or once a director reaches age 65. Distributions in respect of the deferred stock units will be made following termination of service as a director at times established in accordance with the terms of the applicable equity compensation plan of the Issuer Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:00 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 4,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000746 · edgar.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,577 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on January 5, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.